US 8916570
A3 adenosine receptor agonists and antagonists
granted A61PA61P1/00A61P11/00
Quick answer
US patent 8916570 (A3 adenosine receptor agonists and antagonists) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P1/00, A61P11/00, A61P11/06, A61P13/12